Within 1 year recurrence group (n = 89) | 1–3 years recurrence(n = 54) | Without variceal recurrence group(n = 10) | P value | |
---|---|---|---|---|
Gender | ||||
Male(n,%) | 58, 65.2 | 36, 66.7 | 6, 60 | 0.91 |
Female(n,%) | 31, 34.8 | 18, 33.3 | 4, 40 | |
Endoscopic treatment | 0.02 | |||
EVL(n,%) | 39, 43.8 | 14, 25.9 | 1, 10 | |
EIS(n,%) | 39, 43.8 | 32, 59.3 | 9, 90 | |
EVL + EIS(n,%) | 11, 12.4 | 8, 14.8 | 0, 0 | |
Variceal diameter(cm) | 1.22 ± 0.31 | 1.20 ± 0.3 | 0.9 ± 0.2 | 0.03 |
Red signs before treatment(Y/N) | 68/21 | 36/18 | 5/5 | 0.14 |
Gastric varices(Y/N) | 26/63 | 13/41 | 0/10 | 0.13 |
Diameter of peri-ECV(mm) | 3.7 ± 1.4 | 2.5 ± 1.1 | 1.7 ± 0.9 | 0.0 |
Existence or not of PFV (Y/N) | 57/32 | 2/52 | 0/10 | 0.0 |
Diameter of PFV(mm) | 1.9 ± 1.6 | 0.1 ± 0.4 | 0 | 0.0 |
Diameter of para-ECV(mm) | 6.5 ± 2.2 | 5.9 ± 1.9 | 6.9 ± 3.7 | 0.28 |
Primary/secondary preventions(n) | 15/74 | 13/41 | 3/7 | 0.44 |
Child-Pugh grade(n,%) | 0.04 | |||
A | 49, 55.1 | 39, 72.2 | 8, 80 | |
B | 27, 30.3 | 14, 25.9 | 2, 20 | |
C | 13, 14.6 | 1, 1.9 | 0, 0 | |
Child-Pugh score | 7.3 ± 2.1 | 6.5 ± 1.4 | 6.4 ± 0.9 | 0.025 |
MELD score | 7.1 ± 7.8 | 6.9 ± 4.9 | 5.3 ± 2.0 | 0.72 |
CT angiography | ||||
Veins around the esophagus(Y/N) | 81/8 | 50/4 | 9/1 | 0.93 |
Veins around fundus (Y/N) | 63/26 | 38/16 | 6/4 | 0.77 |
Other collateral vein(Y/N) | 12/77 | 11/43 | 2/8 | 0.53 |
Portal vein embolus(Y/N) | 25/64 | 10/44 | 3/7 | 0.41 |
With liver cancer/cirrhosis | 8/81 | 9/45 | 2/8 | 0.31 |
Etiology of cirrhosis(n, %) | 0.28 | |||
hepatitis B | 60, 67.4 | 33, 61.1 | 7, 70 | |
hepatitis C | 2, 2.2 | 8, 14.8 | 1, 10 | |
alcoholic liver disease | 14, 15.7 | 4, 7.4 | 1, 10 | |
nonalcoholic fatty liver disease | 6, 6.8 | 3, 5.6 | 1, 10 | |
autoimmune liver disease | 6, 6.8 | 4, 7.4 | 0, 0 | |
unknown causes | 1, 1.1 | 2, 3.7 | 0, 0 |